Skip to Main Navigation

Kyrgyz Republic Emergency COVID-19 Project - Additional Financing

Abstract*

COMPONENT 1: EMERGENCY COVID-19 RESPONSE (US$ 31.48 million): This component supports the capacity of the Kyrgyz health system to detect, contain, manage, and treat COVID-19 disease. This component will also finance the deployment of COVID-19 vaccines, including vaccine acquisition, systems for vaccine delivery, and follow-up. Supported activities include: Sub-component 1.1 Case Detection, Containment, Confirmation, Recording, and Contact Tracing...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prepare and respond to the COVID-19 pandemic in the Kyrgyz Republic.

Key Details

Project Details

  • P176054

  • Active

  • Christel Vermeersch , Asel Sargaldakova

  • The Kyrgyz Republic

  • Kyrgyz Republic

  • April 27, 2021

  • (as of board presentation)

    June 3, 2021

  • N/A

  • US$ 20.00 million

  • Ministry of Health and Social Development,Ministry of Health

  • Europe and Central Asia

  • 2021

  • US$ 20.00 million

  • N/A

  • N/A

  • June 30, 2024

  • Yes

  • BANK APPROVED

  • P173766

  • March 28, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 10.00
IDA Grant 10.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 20.00
IBRD + IDA Commitment 20.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 20.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)

Footnotes

Ratings

IMPLEMENTATION RATINGS

No data available.

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

No data available.